Key result
Surgical resection of cardiac myxomas resulted in a low hospital mortality of 2.2%, a long-term mortality of 15.6%, and a recurrence rate of 2.7% over a median follow-up of 76 months.
Why the study?
Cardiac myxoma is a rare benign cardiac tumor, and the study aimed to review a 12-year experience in its surgical treatment with emphasis on clinical, pathologic, diagnostic, and surgical features.
Population
90 patients with cardiac myxomas surgically treated at a single institute
Design
Single-center retrospective observational study
Follow-up
Median 76 (1-216) months
Authors
Loading...
Resection yields low mortality/recurrence in this cohort; supports current practice but leaves open need for prospective multicenter validation.
Observational (n=90)
No
Surgical excision of cardiac myxomas yields excellent short- and long-term outcomes with a low recurrence rate (2.7%) and low hospital mortality (2.2%).
Gašparovič et al. (2023) conducted an observational in Cardiac myxoma (n=90). Surgical resection was evaluated on Hospital mortality. Surgical resection of cardiac myxomas resulted in a low hospital mortality of 2.2%, a long-term mortality of 15.6%, and a recurrence rate of 2.7% over a median follow-up of 76 months.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: